Technology · 1 views

Relay Therapeutics Insider Sells 21 , 000 Shares for $166 , 700 After 65 % Run

This clinical-stage biotech focused on precision oncology therapies reported an insider sale amid a year of sharp share price gains.

Source finance.yahoo.com AI Summary Updated February 8, 2026

Story intelligence Beta

Freshness Stale Updated February 8, 2026

Confidence Limited Single-outlet story

Coverage Single outlet

Views 1 Community interest

Read time 1 min ~20 words

AI Summary

This clinical-stage biotech focused on precision oncology therapies reported an insider sale amid a year of sharp share price gains.

Read full article on Finance

AI summaries can be wrong sometimes—always verify important details using the source article.

SUPPORT HAPPENINGNOW · Independent AI News Intelligence

SUPPORTER MESSAGE

Enjoyed this article? Consider supporting HappeningNow to help keep independent AI-powered news analysis moving forward. Your contribution helps cover infrastructure, AI summaries, and continued platform development.

Support HappeningNow